These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925 [TBL] [Abstract][Full Text] [Related]
3. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001. JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482 [No Abstract] [Full Text] [Related]
4. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Dec; 50(48):1077-9. PubMed ID: 11770501 [TBL] [Abstract][Full Text] [Related]
5. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. Borio L; Frank D; Mani V; Chiriboga C; Pollanen M; Ripple M; Ali S; DiAngelo C; Lee J; Arden J; Titus J; Fowler D; O'Toole T; Masur H; Bartlett J; Inglesby T JAMA; 2001 Nov; 286(20):2554-9. PubMed ID: 11722269 [TBL] [Abstract][Full Text] [Related]
6. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472 [TBL] [Abstract][Full Text] [Related]
7. When bioterrorism strikes: diagnosis and management of inhalational anthrax. Shafazand S Semin Respir Infect; 2003 Sep; 18(3):134-45. PubMed ID: 14505276 [TBL] [Abstract][Full Text] [Related]
8. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related Anthrax--Connecticut, 2001. JAMA; 2002 Jan; 287(1):34-5. PubMed ID: 11797623 [No Abstract] [Full Text] [Related]
9. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591 [TBL] [Abstract][Full Text] [Related]
13. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. JAMA; 2001 Nov; 286(18):2226-32. PubMed ID: 11757528 [No Abstract] [Full Text] [Related]
15. From the Centers for Disease Control and Prevention. Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. JAMA; 2001 Nov; 286(17):2086-8. PubMed ID: 11757496 [No Abstract] [Full Text] [Related]
18. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Centers for Disease Control and Prevention JAMA; 2001 Nov; 286(19):2392-6. PubMed ID: 11759667 [No Abstract] [Full Text] [Related]
19. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. JAMA; 2001 Nov; 286(20):2536-7. PubMed ID: 11763846 [No Abstract] [Full Text] [Related]
20. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001. Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]